Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

ATRX Gene Sequencing (NGS) for Alpha-Thalassemia/Mental Retardation Syndrome in UAE

Executive Summary & Core Metrics

Diagnostic Precision

99.9% Diagnostic Sensitivity via ISO 15189-accredited NGS processing and dual-strand confirmation.

Premium Logistics

VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.

Post-Test Clinical Guidance

Telephonic result interpretation with a DHA-licensed genetic counsellor within 48 hours of report release.

Insurance & Payment

Direct Billing Verification via WhatsApp +971 54 548 8731. All major UAE insurers accepted.

Test Overview & Methodology

The ATRX gene sequencing test detects pathogenic variants in the ATRX gene that cause X-linked alpha-thalassemia/mental retardation syndrome (ATR-X syndrome), characterised by severe intellectual disability, distinctive facial features, urogenital anomalies, and HbH disease. This NGS assay sequences the entire coding region and intron-exon boundaries, providing a definitive molecular diagnosis and enabling tailored haematological and neurodevelopmental management.

Feature Our Test (NGS) Sanger Sequencing (Alternative)
Diagnostic Yield >99.9% of all coding variants, including large indels detected by coverage analysis ~80% (misses deep intronic variants and large deletions)
Turnaround Time 3–4 weeks 6–8 weeks (multi-amplicon)
Method Targeted NGS on Illumina NovaSeq 6000, aligned to GRCh38, analysed with ISO-validated bioinformatics pipeline Capillary electrophoresis, manual variant calling
Regulatory Compliance ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), Federal Decree-Law No. 45 of 2021 (PDPL), Federal Law No. 2 of 2019 Variable

Physician Insight & Safety Protocols

“As a Consultant Medical Genetics with DHA, I confirm that ATRX gene sequencing is the gold standard for diagnosing ATR-X syndrome. Results must be interpreted alongside clinical haematological and neurodevelopmental assessments. A variant of uncertain significance requires expert genetic counselling and family segregation studies.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA: 9294403

⚠️ Advisory: Medication & Safety

Do not discontinue prescribed medications without consulting your doctor. This test does not replace urgent medical care.

⚠️ Exclusion Criteria

  • Patients with active haemolysis requiring urgent transfusion
  • Inability to provide informed consent for genetic testing under UAE law
  • Haemolysed, clotted, or grossly contaminated samples; insufficient DNA quantity (<50 ng/μL)

Emergency Red Flags: Severe pallor, acute respiratory distress, seizures, or loss of consciousness – seek immediate medical attention.

Patient FAQ & Clinical Guidance

1. What sample types are accepted for the ATRX gene test?

We accept whole blood (3–5 mL in EDTA), extracted DNA, or a single drop of blood blotted on an FTA card, all transported under cold-chain conditions to preserve nucleic acid integrity.

2. How should I prepare for the home collection service?

No fasting is required; simply hydrate well and provide your Emirates ID. Our phlebotomist will bring all necessary equipment, including the ISO-validated cold-chain vaccine carrier.

3. What is the diagnostic accuracy of this NGS test for ATR-X syndrome?

With >99.9% analytical sensitivity for single-nucleotide variants and copy-number changes, this identifies all known pathogenic ATRX mutations reported in ClinVar and the Human Gene Mutation Database.

UAE Regulatory & Data Privacy Adherence

Legal & Regulatory Compliance

This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is encrypted and handled with strict confidentiality.

Contact for inquiries: +971 54 548 8731

Clinical & Logistical Metadata

Test Name ATRX Gene Sequencing (NGS) for Alpha-Thalassemia/Mental Retardation Syndrome
Price (AED) 2,800 AED
Turnaround Time 3–4 weeks
Sample Type / Matrix Whole blood (3–5 mL in EDTA), extracted DNA, or FTA card
Methodology Used Targeted NGS on Illumina NovaSeq 6000, alignment to GRCh38, ISO-validated bioinformatics pipeline
ICD-10-CM Code Q87.0 (Alpha-thalassemia/mental retardation syndrome)
LOINC Code 84410-0 (ATRX gene mutations identified by sequencing)
DHA Facility License & Laboratory Address DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians